New Hampshire Trust Novartis Ag Transaction History
New Hampshire Trust
- $475 Billion
- Q4 2024
A detailed history of New Hampshire Trust transactions in Novartis Ag stock. As of the latest transaction made, New Hampshire Trust holds 8,374 shares of NVS stock, worth $932,863. This represents 0.17% of its overall portfolio holdings.
Number of Shares
8,374
Previous 8,511
1.61%
Holding current value
$932,863
Previous $979 Million
16.76%
% of portfolio
0.17%
Previous 0.21%
Shares
9 transactions
Others Institutions Holding NVS
# of Institutions
1,478Shares Held
130MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.36 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.23 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$912 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$765 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$621 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $240B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...